With a national distribution network and a full-service contract manufacturing division, SOFIE is the premier choice for the manufacture of molecular imaging probes and theranostics for FDA-approved commercial use as well as for diagnostic, therapeutic, and theranostic trials.
SOFIE provides a range of FDA-approved PET diagnostic imaging agents across the US. From 18F-FDG to 11C-Choline, SOFIE's PET tracer manufacturing and distribution network provides 99% on-time delivery and round-the-clock customer service. Backed by a robust 21CFR212 Quality System, we're dedicated to getting your patient the dose they need, when they need it.
From Start to Clinic, SOFIE has a full range of radiopharmaceutical development services for diagnostic and therapeutic compounds from R&D, clinical trials, and commercial manufacturing stages.